Naloxone in ultralow concentration restores endomorphin-1-evoked Ca2+ signaling in lipopolysaccharide pretreated astrocytes

Neuroscience

Volumn 205, Issue , 2012, Pages 1-9

  Block, L ^a   Forshammar, J ^a   Westerlund, A ^b   Bjorklund U ^b   Lundborg, C ^a   Biber, B ^a   Hansson, E ^b  

^a SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Astrocyte; Calcium; Inflammation; Naloxone; Opioids

Indexed keywords

CALCIUM ION; ENDOMORPHIN 1; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LIPOPOLYSACCHARIDE; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; PERTUSSIS TOXIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; ASTROCYTE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL STIMULATION; COCULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; EVOKED CORTICAL RESPONSE; INTERMETHOD COMPARISON; MOLECULAR INTERACTION; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CALCIUM SIGNALING; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; NALOXONE; OLIGOPEPTIDES; PRIMARY CELL CULTURE; RATS; RECEPTORS, OPIOID, MU;

EID: 84858007763     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.12.058     Document Type: Article

References (50)

1. Abbott N.J., Revest P.A., Romero I.A. Astrocyte-endothelial interaction: physiology and pathology. Neuropathol Appl Neurobiol 1992, 18:424-433.
2. Abbott N.J., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
3. Berridge M.J. Inositol trisphosphate and calcium oscillations. Biochem Soc Symp 2007, 74:1-7.
4. Blomstrand F., Khatibi H., Muyderman H., Hansson E., Olsson T., Rönnbäck L. 5-hydroxytryptamine and glutamate modulate velocity and extent of intercellular calcium signalling in hippocampal astroglial cells in primary cultures. Neuroscience 1999, 88:1241-1253.
5. Chen W., Marvizón J.C.G. Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by μ-opioid receptor internalization. Neuroscience 2009, 161:157-172.
6. Connor M., Christie M.D. Opioid receptor signalling mechanisms. Clin Exp Pharmacol Physiol 1999, 26:493-499.
7. Cornell-Bell A.H., Finkbeiner S.M., Cooper M.S., Smith S.J. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science 1990, 247:470-473.
8. Cotrina M.L., Lin J.H., Nedergaard M. Cytoskeletal assembly and ATP release regulate astrocytic calcium signalling. J Neurosci 1998, 21:8794-8804.
9. Crain S.M., Shen K.-F. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci U S A 1995, 92:10540-10544.
10. Crain S.M., Shen K.F. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000, 84:121-131.
11. 2+ transients are attenuated due to IL-β release and rearrangement of actin filaments. Neuroscience 2009, 159:770-779.
12. DeLeo J.A., Tanga F.Y., Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 2004, 10:40-52.
13. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007, 3:138-145.
14. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci 2004, 5:565-575.
15. Fincha J., Janecka A., Costentin J., Do Rego J.C. The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 2007, 59:88-123.
16. +-ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes. J Biol Chem 2011, 286:31586-31597.
17. Giaume C., McCarthy K.D. Control of gap junctional communication in astrocytic networks. Trends Neurosci 1996, 8:319-325.
18. Hamann S., Sloan P.A., Witt W. Low-dose intrathecal naloxone to enhance morphine analgesia:a case report. J Opioid Manag 2008, 4:267.
19. Hansson E. Long-term pain, neuroinflammation and glial activation. Scand. J Pain 2010, 1:67-72.
20. Hansson E., Rönnbäck L. Glial neuronal signaling in the central nervous system. FASEB J 2003, 17:341-348.
21. Hansson E., Rönnbäck L., Persson L.I., Lowenthal A., Noppe M., Alling C., Karlsson B. Cellular composition of primary cultures from cerebral cortex, striatum, hippocampus, brainstem and cerebellum. Brain Res 1984, 300:9-18.
22. 2+ responses in inflammatory activated astrocytes co-cultured with brain endothelial cells. Neuroscience 2008, 155:1237-1249.
23. Hassinger T.D., Guthrie P.B., Atkinson P.B., Bennett M.V.L., Kater S.B. An extracellular signalling component in propagation of astrocytic calcium waves. Proc Natl Acad Sci U S A 1996, 93:13268-13273.
24. Haydon P.G., Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 2006, 86:1009-1031.
25. Horvath G., Agil A., Joo G., Dobos I., Benedek G., Baeyens J.M. Evaluation of endomorphin-1 on the activity of Na(+), K(+) ATP ase using in vitro and in vivo studies. Eur J Pharmacol 2003, 3:291-297.
26. Horvath G., Kekesi G. Interaction of endogenous ligands mediating antinociception. Brain Res Rev 2006, 52:69-92.
27. Huber J.D., Witt K.A., Hom S., Egleton R.D., Mark S., Davis T.P. Inflammatory pain alters. Blood brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol 2001, 280:H1241-H1248.
28. Hutchinson M.R., Zhang Y., Shridhar M., Evans J.H., Buchanan M.M., Zhao T.W., Slivka P.F., Coats B.D., Rezvani N., Wieseler J., Hughes T.S., Landgraf K.E., Chan S., Fong S., Phipps S., Falke J.J., Leinwand L.A., Maier S.F., Yin H., Rice K.C., Watkins L.R. Evidence that opioids may have Toll-like receptor 4 and MD-2 effects. Brain Behav Immun 2010, 24:83-95.
29. +-ATPase expression in inflammation-pretreated astrocytes. J Neurochem 2011, 119:686-696.
30. +, ATP-ase. Brain Res 2002, 2:311-319.
31. Mattioli T.-A.M., Milne B., Cahill C.M. Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats. Mol Pain 2010, 6:22. http://www.molecularpain.com/content/6/1/22.
32. McMahon S.B., Malcangio M. Current challenges in glia-pain biology. Neuron 2009, 64:46-54.
33. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009, 10:23-36.
34. Mizoguchi H., Tseng L.F., Suzuki T., Sora I., Narita M. Differential mechanism of G-protein activation induced by endogenous mu-opioid peptides, ndomorphin and beta-endorphin. Jpn J Pharmacol 2002, 89:229-234.
35. Morita M., Higuchi C., Moto C., Kozuka N., Susuki J., Itofusa R., Yamashita J., Kudo Y. Dual regulation of calcium oscillation in astrocytes by growth factors and pro-inflammatory cytokines via the mitogen-activated protein kinase cascade. J.Neurosci 2003, 23:10944-10952.
36. Nakamura T., Shiozaki M., Kurakata S. Synthesis of ceramidated GLA 60 derivatives. Carbohydr Res 2002, 15:1343-1349.
37. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172.
38. Saadé N.E., Jabbur S.J. Nociceptive behaviour in animal models for peripheral neuropathy: spinal and supraspinal mechanisms. Prog Neurobiol 2008, 86:22-47.
39. Scemes E., Giaume C. Astrocyte calcium waves: what they are and what they do. Glia 2006, 54:716-725.
40. Sharma G., Vijayaraghavan S. Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci U S A 2001, 98:4148-4153.
41. Shen K.-F., Crain S.M. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res 1997, 757:176-190.
42. Suter M.R., Wen Y.-R., Decosterd I., Ji R.-R. Do glial cells control pain?. Neuron Glia Biol 2007, 3:255-268.
43. Tsai R.-Y., Tai Y.-H., Tzeng J.-I., Cherng C.-H., Yeh C.-C., Wong C.-S. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of μ-opioid receptors from Gs-protein to coupling to Gi-protein. Neuroscience 2009, 164:435-443.
44. Uhl G.R., Childers S., Pasternak G. An opiate-receptor gene family reunion. Trends Neurosci 1994, 17:89-93.
45. Vallejo R., Tilley D.M., Vogel L., Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Practice 2010, 10:167-184.
46. Vanderah T.W. Delta and kappa opioid receptors as suitable drug targets for pain. Clin J Pain 2010, 26:S10-S15.
47. Wang H.-Y., Burns L.H. Naloxone's pentapeptide binding site on filamin A blocks Mu Opioid receptor-Gs coupling and CREB activation of acute morphine. PLoS ONE 2009, http://www.ploseone.org.
48. Wang H.-Y., Friedman E., Olmestead M.C., Burns L.H. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in Mu Opioid receptor-G protein coupling and Gβγ signalling. Neuroscience 2005, 135:247-261.
49. Willis C.L., Davis T.P. Chronic inflammatory pain and the neurovascular unit: A central role for glia in maintaining BBB integrity?. Curr Pharmacet. Design 2008, 14:1625-1643.
50. Zielasek J., Hartung H.P. Molecular mechanisms of microglial activation. Adv Neuroimmunol 1996, 2:191-222.